Aplastic Anemia

Charles J. Parker, M. D., is a Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, at the University of Utah, the Huntsman Cancer Institute and the George E. Whalen VA Medical Center, Salt Lake City, UT. As a Hematologist, his clinical interests include paroxysmal nocturnal hemoglobinuria, hemochromatosis and porphyria.

Dr. Malcovati is an Associate Professor of Hematology at the University of Pavia Medical School and with special interest and expertise in myeloid neoplasms, in particular, myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Dr. Malcovati's research group has made a significant contribution to understanding the molecular basis of myeloid neoplasms and to the integration of somatic mutations in the clinical management of patients.

Dr. Buckstein's research is clinical and focused on novel biological therapies for MDS and lymphomas. She is a clinician-investigator and interacts closely with the scientists of Sunnybrook Research Institute and elsewhere on collaborative projects

Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in the United Kingdom and United States of America. He is board certified in Internal Medicine, Hematology and Medical Oncology. Currently he is working at Loma Linda Cancer Center and University Hospital. He is the Chief of Adult Hematopietic Stem Cell Transplant. He was also a member of adult bone marrow transplantation team at UNMC in Omaha, NE, and USC in Los Angeles, CA. His interests include malignant hematological disorders, particularly acute and chronic leukemias as well as